CN1562991A - New ramification of diterpenes possessing periodic inhibitory action like matricyte of sea star egg - Google Patents

New ramification of diterpenes possessing periodic inhibitory action like matricyte of sea star egg Download PDF

Info

Publication number
CN1562991A
CN1562991A CN 200410026676 CN200410026676A CN1562991A CN 1562991 A CN1562991 A CN 1562991A CN 200410026676 CN200410026676 CN 200410026676 CN 200410026676 A CN200410026676 A CN 200410026676A CN 1562991 A CN1562991 A CN 1562991A
Authority
CN
China
Prior art keywords
starfish
compound
cell
new
sea
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN 200410026676
Other languages
Chinese (zh)
Other versions
CN1268622C (en
Inventor
姚新生
刘宏伟
浪越通夫
小林久芳
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shenyang Pharmaceutical University
Original Assignee
SHENZHEN RESEARCH CENTER OF TRADIONAL CHINESE MEDICINE AND NATURAL MEDICINE
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SHENZHEN RESEARCH CENTER OF TRADIONAL CHINESE MEDICINE AND NATURAL MEDICINE filed Critical SHENZHEN RESEARCH CENTER OF TRADIONAL CHINESE MEDICINE AND NATURAL MEDICINE
Priority to CN 200410026676 priority Critical patent/CN1268622C/en
Publication of CN1562991A publication Critical patent/CN1562991A/en
Application granted granted Critical
Publication of CN1268622C publication Critical patent/CN1268622C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

In this invention, novel diterpenoid compound is extracted from strongylophora strongylata from the sea near Japan. said compound can eliminating egg mother cell of starfish from maturity in vitro. So, it can eliminate more starfish growth to protect fry. It can also be biochemical reagent for researching cell division in vitro. Due to the similar molecular action principle of oocyte maturation of starfish and eucell G2/M period transforming, depending on cyclin B/cdc 2 kinase activation, so it can be used as inhibitor for tumor potentially.

Description

Has inhibiting new diterpenes derivative of sea star egg parent cell cycle
Technical field: what the present invention relates to that separation obtains from the sponge (Phyllospongiadendyi) that West Pacific Ocean's Palau (Palau) archipelagic sea is gathered a plurality ofly has a sea star egg parent cell cycle and suppresses active following new diterpene-kind compound.These compounds can significantly suppress the maturation division of sea star egg parent cell in vitro tests, not only can be used for preventing and treating the region following the line of the sea because of a large amount of breedings of starfish to the infringement that ocean fry aquaculture etc. causes, also can be used as the biochemical reagents of in vitro study cell fission mechanism.
Figure A20041002667600031
Background technology and document: the ocean is a Source of life, it also is the abundantest field of physical resources on the earth, marine organisms are different from terrestrial life, because the difficult harshness (high salt, high pressure, anoxic etc.) of its living environment, for seeking survival and compete living space, a lot of marine organisms can metabolism in the evolution of long period of time process produce the secondary metabolite of some structure uniquenesses.Modern pharmacological research shows that a lot of marine organisms secondary metabolites also have better curative effect to the multiple disease of the mankind, thereby causes chemist, biologist, pharmacologist's etc. very big interest.
The research of marine drug originates in the beginning of the sixties at the end of the fifties in the world.To the later stage eighties, because huge advance made, especially the high resolution NMR broad application of science and technology, the structure determination work of the minor compound that makes becomes quite easy, the research of the marine bioactivity material hot topic that becomes.The various countries scholar has carried out in succession that marine organisms are antitumor, antiviral, antimycotic, resisting cardiovascular is sick, the research of anti-AIDS isoreactivity composition.In the past few decades, about more than 6000 kinds of marine natural products are found, and wherein have the new compound of the active patent applied for of important biomolecule that kind more than 300 is arranged [1,2]The generation development of unusual and a lot of diseases of cell cycle all has confidential relation, and the intravital most of cell of Mammals is in resting stage (G0 phase) under the normal circumstances, has only under certain condition (as factors stimulated growth) just to enter the G1 phase.Cell after the division mostly reenters the G0 phase or is differentiated to form sophisticated not somatoblast, and minority enters the G1 phase and divides next time.The periodicity of cell mitogen and succession explanation cell cycle are processes that is subjected to strict regulation and control, in case defective appears in certain link, just may cause uncontrolled cellular proliferation, and then produce tumour.Extensive screening cell cycle inhibitor, (Flow Cytometry, FCM), but this method needs expensive instrument, complicated operation generally to adopt the flow cytometry method.The sea star egg parent cell is because of its following feature that has, as: Fine born of the same parents' cycle regulating mechanism is similar to eukaryotic cell cycle regulating mechanism; And Fine born of the same parents' cycle spontaneously is synchronized with the early stage of initial meiosis, i.e. the G2/M phase; Immature egg cell and mature egg cell be easy to differentiate at microscopically, obtained using effectively as a kind of cell cycle inhibitor screening method of simple and convenient [3,4]The applicant adopts this method for screening active ingredients, successfully separates to obtain a plurality ofly having a sea star egg parent cell cell cycle and suppressing active new diterpene-kind compound from the sponge (Phyllospongia dendyi) that West Pacific Ocean's Palau (Palau) archipelagic sea is gathered.
Reference:
[1]Faulkner?DJ,marine?pharmacology.Antonie?van?leeuwenhoek?77:135-145[2]Faulkner?DJ,marine?natural?products.Nat?Prod?Rep?19:1-48
[3]Morinaga,C.,Izumi,K.,Sawada,H.,Sawada,M.T.,Activation?of?maturation?promoting?factorand?26S?proteasome?assembly?accelerated?by?a?high?concentration?of?1-methyladenine?instarfish?oocytes.,Biosci.Biotechnol.Biochem,2000,64,268-274.
[4]Toraya,T.;Maoka,T.;Tsuji,H.;Kobayashi,M.Purification?and?structural?determination?of?aninhibitor?of?starfish?oocyte?maturation?from?a?Bacilus?speciese.,Applied?and?Environ.Micro.,1995,61,1799-1804
Summary of the invention: the present invention relates to have the provide protection that the sea star egg parent cell cycle suppresses active new diterpene-kind compound and be used to prevent and treat the infringement that ocean fry aquaculture etc. is caused because of a large amount of breedings of starfish, and as the application of cell division cycle inhibitor.
Embodiment embodiment 1: the separation method of new diterpene-kind compound:
The raw materials used sponge of the present invention (Strongyphora strongylata) is picked up from table island, Japan west, and is frozen in-20 ° refrigerator.Take out sponge during application, at room temperature thaw, chopping, with 3 times of weight dehydrated alcohol extraction 3 times, united extraction liquid, drying under reduced pressure.Residue is scattered in isopyknic water, with isopyknic chloroform extraction 2 times, combined chloroform layer, vacuum decompression drying, chloroform extract.With carrying out chromatographic separation, the methanol-water gradient elution with the open post of anti-phase ODS filler.60% methanol-water wash-out part obtains compound 1,2 through reversed phase high efficiency liquid phase separation (65% methanol-water); 70% methanol-water wash-out part obtains compound 5 through reversed phase high efficiency liquid phase separation (73% methanol-water); The active stream part of 80% methanol-water wash-out part obtains compound 3,4,6 through reversed phase high efficiency liquid phase separation (78% methanol-water) again.
Compound 1 and 2: white powder, UV (MeOH) λ MaxNm (ε): 203 (8450), 293 (3264); HRFABMS, m/z430.2706[M] +(calcd for C 26H 38O 5, 430.2719); 13C and 1H NMR data see Table 2.
Compound 3 and 4: white powder, UV (MeOH) λ MaxNm (ε): 204 (12882), 220 (s, 4097), 230 (s, 3074), 296 (2085); HRFABMS, m/z 412.2595[M] +(calcd for C 26H 36O 4, 412.2614); 13C and 1H NMR data see Table 2.
Compound 5: white powder, UV (MeOH) λ MaxNm (ε): 208 (10865), 220 (s, 6580), 228 (s, 5752), 250 (1592), 257 (1558), 263 (s, 1340), 296 (3396); HRFABMS, m/z 414.2774[M] +(calcd for C 26H 38O 4, 414.2770); 13C and 1H NMR data sees Table 2.
Compound 6: white powder, white powder, UV (MeOH) λ MaxNm (ε): 206 (9257), 220 (s, 4696), 229 (s, 4015), 295 (2089); HRFABMS, m/z 398.2792[M] +(calcd for C 26H 38O 3, 398.2821); 13C and 1The HNMR data see Table 2.
Compound 7: white powder, UV (MeOH) λ MaxNm (ε): 207 (21645), 229 (s, 5434), 257 (2492), 297 (1624); HRFABMS, m/z 427.2465[M+H] +(calcd for C 26H 35O 5, 427.5609); 13C and 1H NMR data data see Table 2.
The 2 sea star egg parent cell cycles of embodiment are suppressed active testing method:
The sea star egg parent cell is the spontaneous early stage that is synchronized with initial meiosis before the ripening stage, i.e. the G2/M phase, in this stage, can observe complete nucleus.Ovum enters the M phase with maturation under the effect of hormone (1-methyladenines) but induce in maturation, and nucleus breaks and carries out reduction division.
It is littoral that female starfish (Asterina pectinifera) individuality picks up from Japan, gathers in annual 4-5 month and 8-10 month, cultures that (ASW, 10mM EPPS-NaOH (pH8.2) contains 0.46M NaCl, 10mM KCl, 35.9mMMgCl in artificial seawater 2, 1.75mM MgSO 4, and 9.18mM CaCl 2) in.Get one of female starfish Asterina pectinifera, cut off, take out red ovary, put into artificial seawater washing 2-3 time of calcium ions not, be suspended in the not calcareous artificial seawater of 30mL along each tentacle center.Ovary is shredded, remove floating follicular cell, three layers of filtered through gauze.Low-speed centrifugal is suspended in the precipitation that obtains in the 200ml artificial seawater then, and microscopic count transfers to 100/ml with cell count, promptly gets required starfish immature egg parent cell.
Laboratory sample is dissolved in DMSO, and concentration is 2mg/ml, as test liquid.The starfish immature egg parent cell of getting 1ml adds in 24 orifice plates, the test liquid 10ul that adds different concns simultaneously, cultivate after 10 minutes on the ice bath, add 1.25uM1-methyladenines 100ul, act on after 50 minutes, the form of observation of cell nuclear under inverted microscope, if compare with negative blank group, nucleus is kept perfectly and shows that promptly the sea star egg cell mature process is had the activity of inhibition.Starfish oocyte maturation inhibiting rate is calculated as follows.
Table 1: compound 1-7 is active to the sophisticated inhibition of sea star egg parent cell
Compound Active (IC 50)
????1 ????2 ????3 ????4 ????5 ????6 ????7 ????35.0μM ????35.0μM ????36.4μM ????36.4μM ????1.2μM ????35.2μM ????36.4μM
Table 2: compound 1-7's 13C-NMR spectrum data (pyridine-d 5, 500MHz)
C#???????1??????????2???????????3??????????4???????????5???????????6???????????7
1????????40.4???????40.4????????40.5???????40.5????????35.6????????35.0????????39.9
2????????22.8???????22.9????????22.9???????22.7????????19.2????????19.0????????20.1
3????????35.3???????40.9????????35.1???????40.7????????36.4????????42.1????????40.3
4????????37.3???????37.1????????37.4???????37.1????????39.1????????33.2????????43.2
5????????51.1???????48.7????????51.5???????49.1????????57.3????????57.0????????49.7
6????????19.8???????20.0????????21.0???????20.4????????18.9????????18.4????????21.2
7????????40.1???????40.6????????38.9???????39.3????????42.9????????41.9????????31.9
8????????39.4???????39.7????????36.4???????36.6????????37.5????????37.5????????43.5
9????????56.9???????57.5????????56.9???????57.6????????62.4????????62.1????????46.3
10???????37.8???????37.6????????37.9???????37.7????????42.4????????42.8????????36.7
11???????17.6???????17.6????????19.0???????18.0????????22.1????????22.5????????19.1
12???????44.7???????44.7????????42.1???????42.1????????43.0????????43.1????????39.9
13???????73.8???????73.8????????76.3???????76.3????????76.7????????76.7????????74.0
14???????63.0???????63.0????????53.0???????53.0????????53.4????????53.4????????99.6
15???????27.6???????27.6????????22.9???????22.9????????23.1????????23.0????????31.9
16???????131.9??????131.9???????123.5??????123.5???????123.5???????123.5???????130.1
17???????149.9??????149.9???????146.8??????146.8???????146.9???????146.8???????154.0
18???????117.7??????117.7???????118.0??????118.0???????118.0???????118.0???????108.7
19???????114.6??????114.6???????115.3??????115.3???????115.3???????115.3???????114.4
20???????151.3??????151.3???????152.2??????152.2???????152.0???????152.0???????152.6
21???????119.4??????119.4???????116.9??????116.9???????116.9???????116.8???????112.4
22???????24.7???????24.7????????21.0???????21.0????????20.5????????20.5????????24.9
23???????16.4???????16.5????????15.7???????15.7????????15.5????????15.6????????17.5
24???????67.9???????62.0????????67.9???????62.0????????62.2????????61.5????????73.8
25???????24.3???????24.1????????24.0???????24.2????????28.6????????34.2????????23.5
26???????98.9???????99.1????????98.9???????99.1????????64.9????????22.0????????176.1
Table 3: compound 1-6,8 1H-NMR spectrum data (pyridine-d 5, 500MHz)
C#????1?????????????2???????????????3??????????????4???????????????5???????????????????????6??????????????????????7
1.00,m???????1.00,m?????????1.00,m????????1.00,m?????????0.77,m?????????????????0.67,m????????????????0.86,m
1
2.17,m???????2.17,m?????????2.17,m????????2.17,m?????????2.51,m?????????????????2.53,m????????????????1.95,m
1.55,m???????1.56,m?????????1.56,m????????1.56,m?????????1.45,m?????????????????1.43,m????????????????1.15,m
2
2.84,m???????2.50,m?????????2.83,m????????2.56,m?????????1.88,m?????????????????1.74,m????????????????1.50,m
1.22,m???????1.34,m?????????1.20,m????????1.34,m?????????1.09,m?????????????????1.16,m????????????????1.30,m
3
2.50,m???????1.56,m?????????2.52,m????????1.56,m?????????2.14,m?????????????????1.37,m????????????????1.74,m
5?????0.88,m???????0.80,m?????????1.12,m????????1.04,m?????????1.13,m?????????????????0.90,m????????????????1.15,m
1.25,m???????1.50,m?????????1.06,m????????1.72,m????????????????????????????????????????????????????????1.15,m
6?????????????????????????????????????????????????????????????????1.73,2H,m?????????????1.44,2H,m
1.60,m???????2.50,m?????????1.65,m????????2.60,m????????????????????????????????????????????????????????1.50,m
0.88,m???????0.88,m?????????0.88,m????????0.88,m?????????0.95,m?????????????????1.00,m????????????????1.25,m
7
2.06,m???????2.06,m?????????1.65,m????????1.65,m?????????1.76,m?????????????????1.72,m????????????????1.58,m
9?????0.85,m???????0.85,m?????????0.94,m????????0.94,m?????????1.10,m?????????????????1.03,d(11.0)b?????????2.05,d(12.5)
1.28,m???????1.28,m?????????1.12,m????????1.55,m?????????2.03,m?????????????????2.05,m????????????????1.17,m
11
1.55,m???????1.55,m?????????1.74,m????????1.72,m?????????2.16,m?????????????????2.20,m????????????????1.70,m
1.75,m???????1.75,m?????????1.74,m????????1.74,m?????????1.76,m?????????????????1.74,m????????????????1.93,m
12
2.03,m???????2.03,m?????????2.08,m????????2.08,m?????????2.14,m?????????????????2.12,m????????????????2.22,m
14????1.95,m???????1.95,m?????????1.65,m????????1.65,m?????????1.74,m?????????????????1.72,m
2.65,m???????2.65,m??????????????????????????????????????????????????????????????????????????????????????3.02,d(15.0)
15
2.60,2H,m????2.60,2H,m?????2.66,2H,d,(9.0)??????2.68,2H,m
3.24,m???????3.24,m???????????????????????????????????????????????????????????????????????????????????????3.51,d(15.0)
18????7.18,m???????7.18,m?????????6.98,m????????6.98,m?????????6.99,d(9.0)????????????6.99,d(9.0)???????????6.80,d(9.0)
19????7.10,m???????7.10,m?????????7.04,m????????7.04,m?????????7.04,dd(3.0,9.0)??????7.04,dd(3.0,9.0)?????6.94,d(9.0)
21????7.34,m???????7.34,m?????????7.05,m????????7.05,m?????????7.09,d(3.0)????????????7.09,d(3.0)???????????7.12,br.s
22????1.36,3H,s???1.36,3H,s?????1.17,3H,s????1.16,3H,s?????1.25,3H,s?????????????1.25,3H,s????????????1.38,3H,s
23????0.87,3H,s???0.96,3H,s?????0.75,3H,s????0.86,3H,s?????1.15,3H,s?????????????1.17,3H,s????????????0.96,3H,s
3.65,d(12.5)?3.40,d(12.5)???3.67,d(11.0)??3.42,d(11.0)???4.09,dd(5.5.12.0)??????4.03,dd(5.5,12.0)????4.01,d(12.5)
24
4.17,d(12.5)?4.57,d(12.5)???4.20,d(11.0)??4.61,d(11.0)???4.23,dd(5.5,12.0)?????4.20,dd?(5.5,12.0)???4.76,d?(12.5)
25????1.01,3H,s???1.08,3H,s?????1.03,3H,s????1.11,3H,s?????1.25,3H,s?????????????0.87,3H,s????????????1.18,3H,s
3.75,d(10.0)
26????5.18,br.s????5.06,d(3.3)????5.20,br.s?????5.08,d(3.3)????????????????????????????0.80,3H,s
3.99,d(10.0)
OH????8.02,br.s????7.56,d(3.3)????8.10,br.s?????7.65,d(3.3)

Claims (3)

1. the new diterpene-kind compound that has following array structure.
2, claim 1 described new diterpene-kind compound proves the maturation division that can significantly suppress the sea star egg parent cell in vitro tests, can be used for preventing and treating the infringement that ocean fry aquaculture etc. is caused because of a large amount of breedings of starfish.
3, the described new diterpene-kind compound of claim 1 is as the application of cell division cycle inhibitor.
CN 200410026676 2004-03-31 2004-03-31 New ramification of diterpenes possessing periodic inhibitory action like matricyte of sea star egg Expired - Fee Related CN1268622C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN 200410026676 CN1268622C (en) 2004-03-31 2004-03-31 New ramification of diterpenes possessing periodic inhibitory action like matricyte of sea star egg

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 200410026676 CN1268622C (en) 2004-03-31 2004-03-31 New ramification of diterpenes possessing periodic inhibitory action like matricyte of sea star egg

Publications (2)

Publication Number Publication Date
CN1562991A true CN1562991A (en) 2005-01-12
CN1268622C CN1268622C (en) 2006-08-09

Family

ID=34480692

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 200410026676 Expired - Fee Related CN1268622C (en) 2004-03-31 2004-03-31 New ramification of diterpenes possessing periodic inhibitory action like matricyte of sea star egg

Country Status (1)

Country Link
CN (1) CN1268622C (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010180155A (en) * 2009-02-05 2010-08-19 Nagoya Univ Novel acetylene alcohol derivative, ngf-related active substance and process for producing the same
CN101445499B (en) * 2008-12-25 2011-12-21 中国人民解放军第二军医大学 Diterpenoid antitumor compound and preparation method thereof
CN102417509A (en) * 2011-12-28 2012-04-18 大连美罗中药厂有限公司 Application of three compounds extracted from starfish to promotion of bone fracture healing, and preparation method for three compounds

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101445499B (en) * 2008-12-25 2011-12-21 中国人民解放军第二军医大学 Diterpenoid antitumor compound and preparation method thereof
JP2010180155A (en) * 2009-02-05 2010-08-19 Nagoya Univ Novel acetylene alcohol derivative, ngf-related active substance and process for producing the same
CN102417509A (en) * 2011-12-28 2012-04-18 大连美罗中药厂有限公司 Application of three compounds extracted from starfish to promotion of bone fracture healing, and preparation method for three compounds

Also Published As

Publication number Publication date
CN1268622C (en) 2006-08-09

Similar Documents

Publication Publication Date Title
Hagiwara et al. Development of rotifer strains with useful traits for rearing fish larvae
CN1075927C (en) Tetraploid shellfish
RU2016121600A (en) PHARMACEUTICAL PRODUCT CONTAINING MITCH ALLERGEN EXTRACT (S) AND METHOD FOR PRODUCING IT
Xiang et al. Patterns of expression in the matrix proteins responsible for nucleation and growth of aragonite crystals in flat pearls of Pinctada fucata
Reggi et al. Biomineralization in Mediterranean corals: the role of the intraskeletal organic matrix
CN1939921A (en) Method and apparatus for producing episesamin-rich composition
CN1283778C (en) Culture of Chansi mould strains and extraction and use of anagentic compound therefrom
CN1562991A (en) New ramification of diterpenes possessing periodic inhibitory action like matricyte of sea star egg
Mills et al. Setal development and moult staging in the crayfish Parastacoides tasmanicus (Erichson),(Decapoda Parastacidae)
CN1130970C (en) Method for preparing pure shellfish line
CN1586507A (en) Officinal Dendrobium stem capsule and preparing method
KR101106964B1 (en) Method for isolating and regenerating gametophytes of Ecklonia cava, and for mass production of Ecklonia cava by maturation induction
CN103830964B (en) A kind ofly add ceramic element of polyvinyl chloride powder and preparation method thereof
Jin et al. Effect of temperature on pearl deposition rate and matrix protein gene expressions in Hyriopsis cumingii
CN1626545A (en) Compound extracted from hull and stem of yellow horn, extracting method and application
CN1634921A (en) Crystalline anti-cholinergic tiotropium crystal
CN1250547C (en) Porocess for extracting matrine and sophoridine from sophora alopecuroide
CN1197561C (en) Application of calcium L-threonate in treating cartilage related diseases
CN1931871A (en) New triterpene saponin componds with anticancer activity
Wilkins et al. Identification of 24-O-β-d-Glycosides and 7-Deoxy-Analogues of Okadaic Acid and Dinophysistoxin-1 and-2 in Extracts from Dinophysis Blooms, Dinophysis and Prorocentrum Cultures, and Shellfish in Europe, North America and Australasia
CN1123577C (en) Ocean thalassiomycete hypoxylon polyose and its extracting process and application
Shen et al. The search for Orsten-type fossils in southern China
CN1215169C (en) Production method of corn superoxide dismutase multienzyme
CN1706836A (en) Process of separating fucoxanthin from algae
JP2011015677A (en) Method for producing diarrhetic toxin okadaic acid-dinophysistoxin group or fat-soluble toxin pectenotoxin group

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C41 Transfer of patent application or patent right or utility model
TR01 Transfer of patent right

Effective date of registration: 20090306

Address after: No. 103, Wenhua Road, Liaoning, Shenyang

Patentee after: Shenyang Pharmaceutical University

Address before: Box 4, building 19, C District, Shenzhen hi tech Southern District, Shenzhen, Nanshan District, Guangdong, China

Patentee before: Shenzhen Research Center of Tradional Chinese Medicine and Natural Medicine

ASS Succession or assignment of patent right

Owner name: SHENYANG PHARMACEUTICAL UNIVERSITY

Free format text: FORMER OWNER: SHENZHEN CHINESE MEDICINE AND NATURAL MEDICINE RESEARCH CENTER

Effective date: 20090306

C17 Cessation of patent right
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20060809